Company profile
Radient Technologies Inc.
OTC: RDDTF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Edmonton, ABReports USD
#758 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 34
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ growth stability, market scale
Methodology →Revenue TTM
$2.4M
Rev growth YoY (TTM)
-24.0%
Net income (FY)
-$10.3M
Employees
33
as of 2026-08-30
Market cap
$5.4k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.9M3.6M CAD2022
Net income-$10.3M-12.9M CAD2022
Operating income-$5.3M-6.6M CAD2022
Total assets$22.2M27.7M CAD2022
Liabilities$30.3M37.9M CAD2022
Equity-$8.1M-10.1M CAD2022
Revenue trend
FY2017 – FY2022 · USD
FY17
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Radient Technologies Inc.’s revenue?
Radient Technologies Inc. booked $2.9M in FY2022 revenue, growing 53% year over year — faster than most Healthcare companies we track, at a -357.0% net margin.
Peers · Healthcare
Protara Therapeutics, Inc.43DOSR Holdings, Inc.34DAmexdrug Corporation69BSCWorx Corp.49DStemtech Corporation26DDental Patient Care America, Inc.73BKey facts
CEOPrakash Hariharan
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersEdmonton, AB
ExchangeOTC: RDDTF
Employees33
IPO date2016-12-28
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.